{"product_id":"buchang-business-model-canvas","title":"Buchang Pharmaceutical Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma Business Model Canvas: R\u0026amp;D, Partnerships \u0026amp; Distribution for Sustainable Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Buchang Pharmaceutical’s Business Model Canvas to see how focused R\u0026amp;D, strategic partnerships, and diversified distribution create sustained revenue and competitive advantage. This concise, actionable canvas maps customer segments, key activities, and cost\/revenue drivers. Purchase the full downloadable Word \u0026amp; Excel canvas to use for benchmarking, investor decks, or strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and TCM Institutes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartnering with universities, TCM hospitals and research academies enables Buchang to co-develop evidence-backed formulations and accelerate clinical validation, addressing cardiovascular disease that causes 17.9 million deaths annually. Joint labs focus on mechanistic studies and biomarker discovery for cardio-cerebrovascular indications, shortening translational timelines. Co-authored papers enhance scientific credibility and strengthen regulatory dossiers for market approval.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHerbal Raw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of 2024 Buchang secures GAP-certified growers for consistent, traceable botanicals such as Salvia miltiorrhiza and Panax notoginseng to ensure raw material integrity.\u003c\/p\u003e\n\u003cp\u003eLong-term contracts and cultivation guidance stabilize quality and price while supplier audits and barcode traceability reduce adulteration risks.\u003c\/p\u003e\n\u003cp\u003eStrategic sourcing aligns with sustainable harvesting practices and company ESG targets, improving supply resilience and compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Manufacturers and CMOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuchang partners with GMP-compliant contract manufacturers and CMOs to provide surge capacity and specialized dosage-form capabilities, leveraging a global contract manufacturing market that exceeded $200 billion in 2024. CMOs handle scale-up, tech transfer, and process validation to shorten time-to-market and smooth capex profiles. Quality agreements specify QC, QA, and pharmacovigilance data exchange to ensure regulatory alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistribution and Hospital Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborate with national wholesalers and provincial distributors to penetrate Class II\/III hospitals, which account for about 65% of hospital drug sales in China; hospital pharmacy committees and GPOs drive formulary and tender decisions. Strategic partnerships boost formulary access and tender win rates in a market where centralized procurement covered over 70% of public hospital purchases in 2024. Data-sharing with distributors and hospitals improves demand forecasting and can raise inventory turns by up to 25%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTarget: Class II\/III hospitals (~65% market)\u003c\/li\u003e\n\u003cli\u003eProcurement: centralized \u0026gt;70% (2024)\u003c\/li\u003e\n\u003cli\u003eGatekeepers: pharmacy committees, GPOs\u003c\/li\u003e\n\u003cli\u003eImpact: data-sharing → inventory turns +25%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Insurance Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBuchang integrates with e-prescription platforms, online pharmacies and commercial insurers to enable seamless prescribing and claims; market signals show digital therapeutics\/remote care scale (DTx market ~4.3 billion USD in 2023). Reimbursement pilots in chronic disease report adherence uplifts (~10–15%) and measurable cost offsets via RWE partnerships. Co-branded patient programs drive sustained adherence and retention through shared incentives.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegration: e-prescription, online pharmacies, insurers\u003c\/li\u003e\n\u003cli\u003eReimbursement pilots: adherence +10–15%\u003c\/li\u003e\n\u003cli\u003eRWE partnerships: quantify outcomes \u0026amp; cost offsets\u003c\/li\u003e\n\u003cli\u003eCo-branded programs: improved adherence \u0026amp; retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and TCM partnerships accelerate cardio validation; \u003cstrong\u003e17.9M\u003c\/strong\u003e deaths\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePartnerships with universities and TCM hospitals speed clinical validation for cardio-cerebrovascular indications (cardiovascular deaths 17.9M\/year). GAP-certified growers and long-term supply contracts secure botanicals; GMP CMOs provide scale (global CMO market \u0026gt;$200B in 2024). Distributor, centralized procurement (\u0026gt;70% 2024) and e-prescription\/insurer links raise formulary access and adherence (+10–15%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademia\/TCM hospitals\u003c\/td\u003e\n\u003ctd\u003eClinical R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e17.9M deaths\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAP growers\u003c\/td\u003e\n\u003ctd\u003eRaw material\u003c\/td\u003e\n\u003ctd\u003eTraceable supply (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMOs\u003c\/td\u003e\n\u003ctd\u003eScale \u0026amp; tech transfer\u003c\/td\u003e\n\u003ctd\u003eCMO market \u0026gt;$200B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eHospital access\u003c\/td\u003e\n\u003ctd\u003eCentralized procurement \u0026gt;70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\/insurers\u003c\/td\u003e\n\u003ctd\u003eAdherence \u0026amp; reimbursement\u003c\/td\u003e\n\u003ctd\u003eAdherence +10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Buchang Pharmaceutical detailing its nine blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partners, and cost structure—aligned with real-world operations and strategic priorities; includes competitive advantages and linked SWOT insights to support presentations, investor funding, and data-driven decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable Business Model Canvas for Buchang Pharmaceutical that quickly surfaces pain points—R\u0026amp;D bottlenecks, supply chain risks, and pricing pressures—enabling teams to align on mitigation strategies and iterate solutions in one clean, shareable page.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D of TCM Formulations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesign and optimize multi-herb prescriptions targeting cardio-cerebrovascular conditions, aligning formulations to reduce risk factors underlying the 17.9 million annual global CVD deaths. Standardize actives using fingerprinting, HPLC and quality-by-design to ensure batch consistency and regulatory compliance. Conduct GLP preclinical studies and randomized clinical trials to demonstrate safety and efficacy. File patents and lock proprietary extraction and compounding know-how.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGMP Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGMP manufacturing operates modern extraction, granulation, tablet, capsule and injection plants with full in-process controls and electronic batch record integrity to support regulatory submissions in 2024. Continuous improvement programs cut production variability and costs while targeting double-digit OEE gains. Environmental compliance treats effluent, solvents and biomass to meet national standards and reduce emissions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Market Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrepare NMPA submissions and post-marketing changes to meet Chinese review timelines, supporting provincial tenders across 31 provinces and national volume-based procurement programs; in 2024 Buchang aligns filings to procurement cycles to protect market share. Health-economics dossiers underpin NRDL\/reimbursement negotiations and pricing; pharmacovigilance reports escalated to regulators within 15 days to drive label updates and safety mitigation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Affairs and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMedical Affairs and Education delivers evidence summaries and accredited CME for cardiologists, neurologists and TCM practitioners, driving clinician uptake through targeted 2024 programs. KOL engagement in 2024 secured guideline mentions and strengthened clinical trust via advisory boards and investigator‑led studies. Published 2024 real‑world data support broader adoption and are used to counter misconceptions with comparative and mechanistic evidence.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eKOL network: advisory boards and guideline citations in 2024\u003c\/li\u003e\n\u003cli\u003eCME: targeted programs for cardiology, neurology, TCM in 2024\u003c\/li\u003e\n\u003cli\u003eRWE: 2024 publications to support adoption\u003c\/li\u003e\n\u003cli\u003eMessaging: comparative and mechanistic data to address misconceptions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOmnichannel Sales and Branding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpomnichannel deployment combines hospital reps retail pharmacy promotion and e-commerce operations to drive buchang sales funnel managing dtp campaigns with nmpa-compliant messaging crm targeting prescribers patient cohorts seasonal disease-burden align manufacturing distribution demand peaks supporting faster stock turns reduced stockouts in\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHospital reps + retail + e-commerce\u003c\/li\u003e\n\u003cli\u003eCompliant DTP\/OTC messaging (NMPA-aligned)\u003c\/li\u003e\n\u003cli\u003eCRM for prescribers \u0026amp; patient cohorts\u003c\/li\u003e\n\u003cli\u003eSeasonal\/disease-burden supply alignment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pomnichannel\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti-herb CVD therapy targeting \u003cstrong\u003e17.9M\u003c\/strong\u003e deaths, GMP \u0026amp; NMPA-timed, RCT-backed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign and standardize multi-herb CVD formulations aligned to reduce drivers of 17.9M annual CVD deaths; 2024 filings timed to NMPA procurement cycles. GMP manufacturing with electronic batch records and double-digit OEE targets; environmental controls meet national limits. GLP\/preclinical and RCTs support safety\/efficacy; PV escalations within 15 days. Omnichannel sales plus KOL\/CME and 2024 RWE.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal CVD deaths\u003c\/td\u003e\n\u003ctd\u003e17.9M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePV escalation\u003c\/td\u003e\n\u003ctd\u003e≤15 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOEE target\u003c\/td\u003e\n\u003ctd\u003edouble-digit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory timing\u003c\/td\u003e\n\u003ctd\u003eNMPA procurement-aligned\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact Buchang Pharmaceutical Business Model Canvas you'll receive after purchase. It’s not a mockup—this live preview shows the same structured, editable file provided in full when you download. Buy with confidence: what you see is what you'll get.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56161383907705,"sku":"buchang-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/buchang-business-model-canvas.png?v=1762691687","url":"https:\/\/portersfiveforce.com\/products\/buchang-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}